Fact CheckerSign in

NCT04869384CompletedPhase 4

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma

Source: ClinicalTrials.gov · Last updated 4 Nov 2024

Brief summary (registry, in English)

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients with Asthma

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
158 (actual)
First submitted
27 Apr 2021
Start date
23 Jun 2021
Primary completion date
24 Apr 2024
Lead sponsor
Orion Corporation, Orion Pharma
Diseases
Asthma
NCT number
NCT04869384
EudraCT number
2019-003082-17

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 158
  • From 23 Jun 2021 to the primary completion date, 24 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Main inclusion Criteria:
  • written informed consent
  • male and female subjects with documented diagnosis of asthma
  • age 18 to 65 years
  • ACT score 19 or less at screening
  • treatment wih oral corticosteroids or hospital or emergency department admission due to asthma exacerbation within the past year
  • subject's able to use Easyhaler inhalers and comply with study requirements
    • Main exclusion Criteria:
  • recent (within 1 month) asthma exacerbation
  • concomitant major respiratory disease which may complicate the measurement of asthma control
  • \>20 pack-year history of smoking
  • recent upper or lower respiratory tract infection
  • pregnant or lactating female subjects

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MECS Research GmbH
Coordinator of this site? Confirm its status
BerlinGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.